185 related articles for article (PubMed ID: 31674105)
61. Liver transplantation for colorectal liver metastases: What do we need to know?
Line PD; Ruffolo LI; Toso C; Dueland S; Nadalin S; Hernandez-Alejandro R
Int J Surg; 2020 Oct; 82S():87-92. PubMed ID: 32305529
[TBL] [Abstract][Full Text] [Related]
62. PET-CT as a predictor of outcome in resectable colorectal liver metastases.
Jones C; Badger SA; Stevenson M; Diamond T; McKie LD; Taylor MA; Wilson RH; Lynch TB
Eur J Gastroenterol Hepatol; 2014 Apr; 26(4):466-72. PubMed ID: 24445726
[TBL] [Abstract][Full Text] [Related]
63. A meta-analysis exploring the role of PET and PET-CT in the management of potentially resectable colorectal cancer liver metastases.
Daza JF; Solis NM; Parpia S; Gallinger S; Moulton CA; Belley-Cote EP; Levine MN; Serrano PE
Eur J Surg Oncol; 2019 Aug; 45(8):1341-1348. PubMed ID: 30928334
[TBL] [Abstract][Full Text] [Related]
64. Repeated transarterial chemoembolization in the treatment of liver metastases of colorectal cancer: prospective study.
Vogl TJ; Gruber T; Balzer JO; Eichler K; Hammerstingl R; Zangos S
Radiology; 2009 Jan; 250(1):281-9. PubMed ID: 19092099
[TBL] [Abstract][Full Text] [Related]
65. Transplantation for colorectal liver metastasis.
Line PD; Dueland S
Curr Opin Organ Transplant; 2024 Feb; 29(1):23-29. PubMed ID: 37995153
[TBL] [Abstract][Full Text] [Related]
66. Liver transplantation for patients with metastatic endocrine tumors: single-center experience with 15 patients.
Frilling A; Malago M; Weber F; Paul A; Nadalin S; Sotiropoulos GC; Cicinnati V; Beckebaum S; Bockisch A; Mueller-Brand J; Hofmann M; Schmid KW; Gerken G; Broelsch CE
Liver Transpl; 2006 Jul; 12(7):1089-96. PubMed ID: 16799958
[TBL] [Abstract][Full Text] [Related]
67. High survival rate after two-stage resection of advanced colorectal liver metastases: response-based selection and complete resection define outcome.
Brouquet A; Abdalla EK; Kopetz S; Garrett CR; Overman MJ; Eng C; Andreou A; Loyer EM; Madoff DC; Curley SA; Vauthey JN
J Clin Oncol; 2011 Mar; 29(8):1083-90. PubMed ID: 21263087
[TBL] [Abstract][Full Text] [Related]
68. Liver Transplant for Nonhepatocellular Carcinoma Malignancy.
Haberal Reyhan N
Exp Clin Transplant; 2017 Mar; 15(Suppl 2):69-73. PubMed ID: 28302003
[TBL] [Abstract][Full Text] [Related]
69. Long-term outcomes and recurrence pattern of 18F-FDG PET-CT complete metabolic response in the first-line treatment of metastatic colorectal cancer: a lesion-based and patient-based analysis.
Chiu KWH; Lam KO; An H; Cheung GTC; Lau JKS; Choy TS; Lee VHF
BMC Cancer; 2018 Jul; 18(1):776. PubMed ID: 30064385
[TBL] [Abstract][Full Text] [Related]
70. Liver transplantation in septuagenarians receiving model for end-stage liver disease exception points for hepatocellular carcinoma: the national experience.
Schwartz JJ; Pappas L; Thiesset HF; Vargas G; Sorensen JB; Kim RD; Hutson WR; Boucher K; Box T
Liver Transpl; 2012 Apr; 18(4):423-33. PubMed ID: 22250078
[TBL] [Abstract][Full Text] [Related]
71. Histopathological Helsinki score of colorectal liver metastases predicts survival after liver resection.
Reijonen P; Nordin A; Savikko J; Poussa T; Arola J; Isoniemi H
APMIS; 2023 Jun; 131(6):249-261. PubMed ID: 36919871
[TBL] [Abstract][Full Text] [Related]
72. Liver transplantation in cirrhotic patients with small hepatocellular carcinoma: an analysis of pre-operative imaging, explant histology and prognostic histologic indicators.
Bhattacharjya S; Bhattacharjya T; Quaglia A; Dhillon AP; Burroughs AK; Patch DW; Tibballs JM; Watkinson AF; Rolles K; Davidson BR
Dig Surg; 2004; 21(2):152-9; discussion 159-60. PubMed ID: 15166485
[TBL] [Abstract][Full Text] [Related]
73. Liver transplantation in a patient with unresectable colorectal liver metastases -- a case report.
Hrehoreţ D; Alexandrescu S; Braşoveanu V; Grigorie R; Zielinski C; Popescu I
Chirurgia (Bucur); 2013; 108(5):719-24. PubMed ID: 24157119
[TBL] [Abstract][Full Text] [Related]
74. Liver transplantation for non-resectable colorectal liver metastasis: where we are and where we are going.
Glinka J; Ardiles V; Pekolj J; Mattera J; Sanchez Clariá R; de Santibañes E; de Santibañes M
Langenbecks Arch Surg; 2020 May; 405(3):255-264. PubMed ID: 32333096
[TBL] [Abstract][Full Text] [Related]
75. 3'-Deoxy-3'-
Kim JE; Chae SY; Kim JH; Kim HJ; Kim TW; Kim KP; Kim SY; Lee JL; Oh SJ; Kim JS; Ryu JS; Moon DH; Hong YS
Eur J Nucl Med Mol Imaging; 2019 Jul; 46(8):1713-1722. PubMed ID: 31041456
[TBL] [Abstract][Full Text] [Related]
76. Hepatic cryotherapy and regional chemotherapy with or without resection for liver metastases from colorectal carcinoma: how many are too many?
Yan DB; Clingan P; Morris DL
Cancer; 2003 Jul; 98(2):320-30. PubMed ID: 12872352
[TBL] [Abstract][Full Text] [Related]
77. Predicting survival after liver transplantation in patients with hepatocellular carcinoma using the LiTES-HCC score.
Goldberg D; Mantero A; Newcomb C; Delgado C; Forde KA; Kaplan DE; John B; Nuchovich N; Dominguez B; Emanuel E; Reese PP
J Hepatol; 2021 Jun; 74(6):1398-1406. PubMed ID: 33453328
[TBL] [Abstract][Full Text] [Related]
78. Effect of autotransfusion system on tumor recurrence and survival in hepatocellular carcinoma patients.
Akbulut S; Kayaalp C; Yilmaz M; Ince V; Ozgor D; Karabulut K; Eris C; Toprak HI; Aydin C; Yilmaz S
World J Gastroenterol; 2013 Mar; 19(10):1625-31. PubMed ID: 23538988
[TBL] [Abstract][Full Text] [Related]
79. Comparison of PERCIST and RECIST criteria for evaluation of therapy response after yttrium-90 microsphere therapy in patients with hepatocellular carcinoma and those with metastatic colorectal carcinoma.
Sager S; Akgün E; Uslu-Beşli L; Asa S; Akovali B; Sahin O; Yeyin N; Demir M; Abuqbeitah M; Gülsen F; Sayman H; Sönmezoglu K
Nucl Med Commun; 2019 May; 40(5):461-468. PubMed ID: 30896544
[TBL] [Abstract][Full Text] [Related]
80. Does positron emission tomography/computed tomography change management in colorectal cancer?
Falconer R; Connor S; Balasingam A; Eglinton T
ANZ J Surg; 2018 Apr; 88(4):E248-E251. PubMed ID: 27788564
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
